Role of fecal microbiota transplantation in inflammatory bowel disease
- 25 April 2018
- journal article
- review article
- Published by Wiley in Journal of Digestive Diseases
- Vol. 19 (6) , 322-334
Abstract
There is increasing evidence of the key role played by altered intestinal microbiota in the pathogenesis of inflammatory bowel disease (IBD). Management strategies involving immune modulation are effective and widely used, but treatment failures and side effects occur. Fecal microbiota transplantation (FMT) provides a novel, perhaps complementary, strategy to restore the normal gut microbiota in patients with IBD. This review summarizes the available efficacy and safety data on the use of FMT in patients with IBD. Several aspects remain to be clarified about the clinical predictors of the response to FMT, its most appropriate route of administration, and the most appropriate quantity and quality of microbiota to be transplanted. Further studies focusing on long‐term outcomes and safety are also warranted.Keywords
This publication has 50 references indexed in Scilit:
- Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future DirectionsCurrent Gastroenterology Reports, 2013
- Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organTherapeutic Advances in Gastroenterology, 2013
- IBD—what role do Proteobacteria play?Nature Reviews Gastroenterology & Hepatology, 2012
- Fecal microbiota transplantation and emerging applicationsNature Reviews Gastroenterology & Hepatology, 2011
- Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relativesGut, 2011
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsProceedings of the National Academy of Sciences, 2008
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007
- Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileumThe ISME Journal, 2007
- Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approachGut, 2005